Suchergebnisse - "Khan, Nabeel"

PubPharm (153)

41

Detection of COVID-19 in Chest X-ray Images : A Big Data Enabled Deep Learning Approach

enthalten in: International journal of environmental research and public health | 2021

von Awan, M. | Bilal, M. | Yasin, A. | +3

42

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System

enthalten in: Gut | 2021

von Khan, N. | Mahmud, N. | Trivedi, C. | +2

ErratumIn: Gut. 2021 Nov;70(11):e8. - PMID 34620697

43

Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications

enthalten in: Gastroenterology | 2021

von Khan, N. | Mahmud, N.

44

Iron deficiency anemia in IBD : an overlooked comorbidity

enthalten in: Expert review of gastroenterology & hepatology | 2021

von Shah, Y. | Patel, D. | Khan, N.

45

Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications : A Nationwide Retrospective Cohort Study

enthalten in: Advances in therapy | 2021

von Khan, N. | Pernes, T. | Weiss, A. | +4

46

enthalten in: Gastroenterology | 2021

von Khan, N. | Yang, Y.

CommentOn: Gastroenterology. 2021 Apr;160(5):1903-1904. - PMID 32687929

47

Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study

enthalten in: Advances in therapy | 2021

von Khan, N. | Pernes, T. | Weiss, A. | +4

48

Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study

enthalten in: Advances in therapy | 2021

von Khan, N. | Pernes, T. | Weiss, A. | +4

49

Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study

enthalten in: Advances in therapy | 2021

von Khan, N. | Pernes, T. | Weiss, A. | +4

50

The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients

enthalten in: Crohn's & colitis 360 | 2021

von Khan, N. | Patel, D. | Pernes, T. | +5